Skip to main content

Table 5 Survival analysis was performed by univariate and multivariate Cox regression analysis

From: CILP2 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer in The Cancer Genome Atlas (TCGA) study

Variables Univariate analysis Multivariate analysis
P value HR 95% CI P value HR 95% CI
CILP2 expression (high vs. low) 0.003 1.713 1.194–2.457 0.034 1.547 1.033–2.317
Gender (male vs. female) 0.941 0.987 0.694–1.404 0.132 1.351 0.913–1.999
Age (> 68 vs. ≤ 68) < 0.0001 1.923 1.337–2.767 < 0.0001 2.626 1.743–3.957
T stage (T3/4 vs. T1/2) 0.005 2.457 1.320–4.572 0.143 1.817 0.816–4.044
N stage (N1/2/3 vs. N0) < 0.0001 2.734 1.897–3.942 0.264 0.589 0.232–1.491
M stage (M1 vs. M0) < 0.0001 4.126 2.776–6.133 < 0.0001 2.854 1.769–4.604
Clinical stage (III/IV vs. I/II) < 0.0001 3. 2.046–4.401 0.017 3.408 1.244–9.337
  1. P value < 0.05 was considered statistically significant (in bold). T tumor, N regional lymph node, M metastasis, HR hazard ratio, CI confidence interval